Enovix (NASDAQ:ENVX) Stock Price Down 8.7% – Here’s Why

Enovix Corporation (NASDAQ:ENVXGet Free Report) shares dropped 8.7% on Tuesday . The company traded as low as $5.53 and last traded at $5.4150. Approximately 908,253 shares traded hands during trading, a decline of 86% from the average daily volume of 6,313,135 shares. The stock had previously closed at $5.93.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Wall Street Zen raised shares of Enovix from a “strong sell” rating to a “sell” rating in a research report on Saturday, May 16th. Benchmark lowered their price target on Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a research report on Thursday, May 14th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Enovix in a research report on Friday, April 10th. JPMorgan Chase & Co. downgraded Enovix from a “neutral” rating to an “underweight” rating in a research note on Wednesday, May 6th. Finally, Canaccord Genuity Group cut their price target on Enovix from $21.00 to $15.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Seven analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $12.64.

Check Out Our Latest Report on ENVX

Enovix Stock Up 15.0%

The company has a debt-to-equity ratio of 2.14, a current ratio of 10.97 and a quick ratio of 10.65. The company has a market cap of $1.39 billion, a price-to-earnings ratio of -7.66 and a beta of 2.24. The firm has a 50-day moving average price of $5.88 and a 200 day moving average price of $6.95.

Enovix (NASDAQ:ENVXGet Free Report) last posted its earnings results on Wednesday, May 13th. The company reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.01. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.The company had revenue of $7.60 million during the quarter, compared to the consensus estimate of $6.95 million. During the same quarter last year, the firm earned ($0.15) earnings per share. The company’s revenue was up 49.1% on a year-over-year basis. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. Sell-side analysts predict that Enovix Corporation will post -0.81 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in ENVX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Enovix by 5.1% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 98,318 shares of the company’s stock worth $722,000 after acquiring an additional 4,780 shares during the period. NewEdge Advisors LLC raised its stake in Enovix by 10.4% in the first quarter. NewEdge Advisors LLC now owns 26,257 shares of the company’s stock valued at $193,000 after purchasing an additional 2,481 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in Enovix by 65.4% during the first quarter. Goldman Sachs Group Inc. now owns 1,137,777 shares of the company’s stock worth $8,351,000 after purchasing an additional 449,934 shares during the period. Caxton Associates LLP acquired a new stake in Enovix during the first quarter worth about $190,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Enovix by 18.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 358,023 shares of the company’s stock valued at $2,628,000 after buying an additional 55,676 shares during the period. 50.92% of the stock is owned by institutional investors.

About Enovix

(Get Free Report)

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.

Recommended Stories

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.